Prep

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 07.07.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acronym for HIV pre-exposure prophylaxis. PrEP is a therapeutic procedure with which HIV-negative people who are exposed to a possible risk can protect themselves against HIV infection by taking antiviral medication(emtricitabine + tenovir) as a preventive measure. 2 published studies (PROUD, IPERGAY) have demonstrated the high efficacy of this medication.

Since September 2019, PrEP is a benefit of the statutory health insurance for people with "substantial" HIV risk.

LiteratureThis section has been translated automatically.

  1. McCormack S et al (2016) Pre-exposure prophylaxis prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 387:53-60.
  2. Sagaon-Teyssier L et al (2016) Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. AIDS Care 28 Suppl 1:48-55.
  3. https://www.aerzteblatt.de/nachrichten/132834/-Fazit-nach-mehr-als-zwei-Jahren-HIV-Praeexpositionsprophylaxe-als-Kassenleistung

Authors

Last updated on: 07.07.2023

Author: Prof. Dr. med. Peter Altmeyer